Diamond Biofund Inc. (6901.TW)
TWD 32.0
(-3.03%)
TWD 32.0
(-3.03%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -195.81 Million | 473.08 Million | -300.42 Million | -72.98 Million | -39.57 Million |
| Net Income | -2.58 Billion | 881.12 Million | 2.96 Billion | 6.11 Billion | -370.75 Million |
| Depreciation & Amortization | 9.85 Million | 11.46 Million | 11.86 Million | 12.02 Million | 10.56 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | 10.56 Million | 1.15 Million | - | - |
| Change in working capital | -8.67 Million | 690.79 Million | -182.28 Million | 322.41 Million | -362 Thousand |
| Other non-cash items | 2.38 Billion | -616 Thousand | 432 Thousand | -1.3 Million | -900 Thousand |
| Investing Cash Flow | -26.6 Million | 2.48 Million | 114.84 Million | -114.84 Million | 59.75 Million |
| Investments in PPE | -19.1 Million | -2.04 Million | - | - | -1.48 Million |
| Acquisitions | - | 29 Thousand | - | - | - |
| Investment purchases | -2.37 Billion | - | -4.5 Million | -114.84 Million | - |
| Sales/Maturities of investments | - | 4.5 Million | 119.34 Million | - | 61.23 Million |
| Other Investing Activities | -7.12 Million | -560 Thousand | - | - | - |
| Financing Cash Flow | 4.36 Billion | -159.86 Million | -16.8 Million | -9.31 Million | -9.09 Million |
| Debt repayment | - | - | - | - | - |
| Dividends payments | -127 Million | -150 Million | - | - | - |
| Common Stock Repurchased | - | - | -8.18 Million | - | - |
| Common Stock Issuance | 4.49 Billion | - | - | - | - |
| Other Financing Activities | -3.67 Million | -9.86 Million | - | - | - |
| Accounts receivables | 1.84 Million | -175 Thousand | - | - | - |
| Accounts payables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Other working capital | -10.51 Million | 690.97 Million | - | - | - |
| Cash at beginning of period | 333.84 Million | 18.13 Million | 220.51 Million | 417.66 Million | 405.05 Million |
| Cash at end of period | 2.1 Billion | 333.84 Million | 18.13 Million | 220.51 Million | 416.14 Million |
| Capital Expenditure | -19.1 Million | -2.04 Million | - | - | -1.48 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 1.76 Billion | 315.7 Million | -202.38 Million | -197.14 Million | 11.08 Million |
| Free Cash Flow | -214.92 Million | 471.04 Million | -300.42 Million | -72.98 Million | -41.05 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -134.06 Million | -807.25 Million | 191.39 Million | -1.31 Billion | -1.43 Billion | -27.04 Million |
| Depreciation & Amortization | 7.43 Million | 5.94 Million | 4.68 Million | 244 Thousand | 2.02 Million | 2.9 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 3.16 Million | 3.54 Million | - | 16.52 Million | 3.89 Million | 3.84 Million |
| Change in working capital | 1.79 Million | -2 Billion | -7.46 Million | 65.49 Million | -95.3 Million | -8.8 Million |
| Other non-cash items | 825 Thousand | -5.14 Million | -210.67 Million | -13 Thousand | -592 Thousand | -19 Thousand |
| Investing Cash Flow | -2.16 Million | -12.9 Million | -25.77 Million | -275 Thousand | -555 Thousand | - |
| Investments in PPE | -1.09 Million | -11.83 Million | -18.86 Million | -53 Thousand | -240 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -1.06 Million | -1.07 Million | -6.9 Million | - | - | - |
| Financing Cash Flow | -4.74 Million | 6.37 Million | 5.9 Million | 4.36 Billion | -919 Thousand | -2.75 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 6.37 Million | 5.9 Million | 4.48 Billion | - | - |
| Other Financing Activities | -4.74 Million | - | - | - | - | - |
| Accounts receivables | -1.48 Million | - | 1.84 Million | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 3.27 Million | - | -9.3 Million | - | - | - |
| Cash at beginning of period | 65.92 Million | 2.1 Billion | 4.47 Billion | 88.8 Million | 294.72 Million | 333.84 Million |
| Cash at end of period | 27.09 Million | 65.92 Million | 2.1 Billion | 4.47 Billion | 88.8 Million | 294.72 Million |
| Capital Expenditure | -1.09 Million | -11.83 Million | -18.86 Million | -53 Thousand | -240 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -38.82 Million | -2.03 Billion | -2.37 Billion | 4.39 Billion | -205.92 Million | -39.11 Million |
| Free Cash Flow | -33.01 Million | -2.04 Billion | -40.91 Million | 29.58 Million | -204.69 Million | -36.36 Million |
NITO
MRKS
9300
VIVXF
HG
3684